Moreover presence of insulin resistance and diabetes are risk factors for fibrosis progression and nonresponse to antiviral therapy in chronic hepatitis C (CHC).
This is also the first time researchers have established that a recently discovered antiviral protein called viperin plays a role in our body's defense against rhinovirus.